Interleukin-1β inhibits phospholamban gene expression in cultured cardiomyocytes

Circulation Research

Volumn 81, Issue 4, 1997, Pages 493-503

  McTiernan, Charles F ^a   Lemster, Bonnie H ^b   Frye, Carole ^b   Brooks, Steven ^b   Combes, Alain ^b   Feldman, Arthur M ^b  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^b NONE

Author keywords

Cardiomyocyte; Molecular biology; Phospholamban; Proinflammatory cytokine; RNA

Indexed keywords

ADENOSINE TRIPHOSPHATASE (CALCIUM); NITRIC OXIDE SYNTHASE; PHOSPHOLAMBAN; PROSTAGLANDIN SYNTHASE; PROTEIN TYROSINE KINASE; RECOMBINANT INTERLEUKIN 1BETA; RECOMBINANT TUMOR NECROSIS FACTOR ALPHA; STAUROSPORINE;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; BETA ADRENERGIC STIMULATION; CALCIUM CURRENT; CONTROLLED STUDY; GENE EXPRESSION; HEART MUSCLE CONTRACTILITY; IMMUNOMODULATION; NEWBORN; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; RAT; SARCOPLASMIC RETICULUM; TRANSCRIPTION REGULATION;

EID: 0030792752     PISSN: 00097330     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.RES.81.4.493     Document Type: Article

References (70)

1. Hicks MJ, Shigekawa M. Katz AM. Mechanism by which cyclic adenosine 3′:5′-monophosphate-dependent protein kinase stimulates calcium transport in the cardiac sarcoplasmic reticulum. Circ Res. 1979;44:384-391.
2. 2+ uptake in mammalian ventricular myocytes. Am J Physiol. 1991;261:H1344-H1349.
3. 2+ transport by cyclic 3′:5′-AMP-dependent and calcium-calmodulin-dependent phosphorylation of cardiac sarcoplasmic reticulum. Biochim Biophys Acta. 1985;844:193-199.
4. Luo W, Grupp IL, Harrer J, Ponniah S, Grupp G, Duffy JJ. Doetschman T, Kranias EG. Targeted ablation of the phospholamban gene is associated with markedly enhanced myocardial contractility and loss of β-agonist stimulation. Circ Res. 1994;75: 401-409.
5. Luo W, Wolska BM, Grupp IL, Harrer JM, Haghighi K, Ferguson DG, Slack JP, Grupp G, Doetschman T, Solaro, RJ, Kranias EG. Phospholamban gene dosage effects in the mammalian heart. Circ Res. 1996;78:839-847.
6. 2-adrenergic receptor is associated with reduced phospholamban protein. J Clin Invest. 1996;97:1618-1623.
7. Stein B, Bartel S, Kirchhefer U, Kokott S, Krause E, Neumann J, Schmitz W, Scholz H. Relation between contractile function and regulatory cardiac proteins in hypertrophied hearts. Am J Physiol. 1996;39:H2021-H2028.
8. Feldman AM, Ray PE, Silan CM, Mercer JA, Minobe W, Bristow MR. Selective gene expression in failing human heart: quantification of steady-state levels of messenger RNA in endomyocardial biopsies using the polymerase chain reaction. Circulation. 1991;83:1866-1872.
9. Arai M, Alpert NR, MacLennan DH, Barton P, Perisamy M. Alterations in sarcoplasmic reticulum gene expression in human heart failure: a possible mechanism for alterations in systolic and diastolic properties of the failing myocardium. Circ Res. 1993;72:463-469.
10. 2+-ATPase in failing and nonfailing human hearts. Cardiovasc Res. 1996;31:625-632.
11. Rockman HA, Ono S, Ross RS, Jones LR, Karimi M, Bhargava V, Ross J Jr, Chien KR. Molecular and physiological alterations in murine ventricular dysfunction. Proc Natl Acad Sci U S A. 1994;.91:2694-2698.
12. Williams RE, Kass DA, Kawagoe Y, Pak P, Tunin RS, Shah R, Hwang A, Feldman AM. Endomyocardial gene expression during development of pacing tachycardia-induced heart failure in the dog. Circ Res. 1994;75:615-623.
13. 2+ transport and mechanics in compensated pressure-overload hypertrophy and congestive heart failure. Circ Res. 1995;77:759-764.
14. Mutsui H, MacLennan DH, Alpert NR. Perisamy M. Sarcoplasmic reticulum gene expression in pressure overload-induced cardiac hypertrophy in rabbits. Am J Physiol. 1995;268:C252-C258.
15. 2+-transporting ATPase, phospholamban, and calsequestrin levels in nonfailing and failing human myocardium. Circulation. 1994;90:653-657.
16. Meyer M, Schillinger W, Pieske B, Holubarsch C, Heilmann C., Posival H, Kuwajima G, Mikoshiba K, Just H, Hasenfuss G. Alterations of sarcoplasmic reticulum proteins in failing human dilated cardiomyopathy. Circulation. 1995;92:778-784.
17. 2+-ATPase activity of cardiac sarcoplasmic reticulum from dilated cardiomyopathy patients compared with patients with nonfailing hearts. Circulation. 1995;92:3220-3228.
18. Arai M, Otsu K, MacLennan DH, Alpert NR, Periasamy M. Effect of thyroid hormone on the expression of mRNA encoding sarcoplasmic reticulum proteins. Circ Res. 1991;69:266-276.
19. Giroir B, Horton J, White D, McIntyre K, Lin C. Inhibition of tumor necrosis factor prevents myocardial dysfunction during burn shock. Am J Physiol. 1994;267:H118-H124.
20. Fischer E, Maramo M, Van Zee K, Rock C, Hawes A, Thompson W, DeForge L, Kenney J, Remick D, Bloedow D, Thompson RC, Lowry SF, Moldawer LL. Interleukin-1 receptor blockade improves survival and hemodynamic performance in Escherichia coli septic shock, but fails to alter host responses to sublethal endotoxemia. J Clin Invest. 1992;89:1551-1557.
21. Kumar A, Thota V, Dee L, Olson J, Uretz E, Parillo J. Tumor necrosis factor alpha and interleukin 1beta are responsible for in vitro myocardial cell depression induced by human septic shock serum. J Exp Med. 1996;183:949-958.
22. Neumann D, Lane J, Allen G, Herskowitz A, Rose N. Viral myocarditis leading to cardiomyopathy: do cytokines contribute to pathogenesis? Clin Immunol Immunopathol. 1993;68:181-190.
23. Arbustini E, Grasso M, Diegoli M, Bramerio M, Foglieni AS, Albertario M, Martinelli L, Gavazzi A, Goggi C, Campana C, Vigano M. Expression of tumor necrosis factor in human acute cardiac rejection: an immunohistochemical and immunoblotting study. Am J Pathol. 1991;139:709-715.
24. Levine B, Kalman J, Mayer L, Fillit H, Packer M. Elevated circulating levels of tumor necrosis factor in severe chronic heart failure. N Engl J Med. 1990;323:236-241.
25. Testa M, Yeh M, Lee P, Fanelli R, Loperfido F, Berman J, Le Jemtel T. Circulating levels of cytokines and their endogenous modulators in patients with mild to severe congestive heart failure due to coronary artery disease or hypertension. J Am Coll Cardiol. 1996;28:964-971.
26. Murray DR, Freeman GL. Tumor necrosis factor-α induces a biphasic effect on myocardial contractility in conscious does. Circ Res. 1996;78:154-160.
27. Dinarello C. Biologic basis for interleukin-1 in disease. Blood. 1996;87:2095-2147. Review.
28. Schulz R, Panas D, Catena R, Moncada S, Olley P, Lopaschuk G. The role of nitric oxide in cardiac depression induced by interleukin-1 beta and tumour necrosis factor-alpha. Br J Pharmacol. 1995;114:27-34.
29. Yokoyama T, Vaca L, Rossen R, Durante W, Hazarika P, Mann D. Cellular basis for the negative inotropic effects of tumor necrosis factor-α in the adult mammalian heart. J Clin Invest. 1993;92:2303-2312.
30. Finkel M, Oddis C, Jacob T, Watkins S, Hattler B, Simmons R. Negative inotropic effects of cytokines on the heart mediated by nitric oxide. Science. 1992;257:387-389.
31. Evans H, Lewis MJ, Shah A. Interleukin-1β modulates myocardial contraction via dexamethasone sensitive production of nitric oxide. Cardiovasc Res. 1993;27:1486-1490.
32. Gulick T, Chung M, Pieper S, Lange L, Schreiner G. Interleukin 1 and tumor necrosis factor inhibit cardiac myocyte β-adrenergic responsiveness. Proc Natl Acad Sci USA 1986;86:6753-6757.
33. Thaik C, Calderone A, Takahashi N, Colucci W. Interleukin-1β modulates the growth and phenotype of neonatal rat cardiac myocytes. J Clin Invest. 1995;96:1093-1099.
34. Palmer J, Hartogensis W, Patten M, Fortuin F, Long CS. Interleukin-1β induces cardiac myocyle growth but inhibits cardiac fibroblast proliferation in culture. J Clin Invest. 1995;95:2555-2564.
35. Patten M, Hartogensis W, Long CS. Interleukin-1β is a negative transcriptional regulator of α1-adrenergic induced gene expression in cultured cardiac myocytes. J Biol Chem. 1996;271:21134-21141.
36. Stein B, Frank P, Schmitz W, Scholz H, Thoenes M. Endotoxin and cytokines induce direct cardiodepressive effects in mammalian cardiomyocytes via induction of nitric oxide synthase. J Mol Cell Cardiol. 1996;28:1631-1639.
37. Luss H, Watkins S, Fieeswick P, Imro A, Nussler A, Billiar T, Simmons R, del Nido P, McGowan F. Characterization of inducible nitric oxide synthase expression in endotoxemic rat cardiac myocytes in vivo and following cytokine exposure in vitro. J Mol Cell Cardiol. 1995;27:2015-2029.
38. Shindo T, Ikeda U, Ohkawa F, Kawahara Y, Yokoyama M, Shimada K. Nitric oxide synthesis in cardiac myocytes and fibroblasts by inflammatory cytokines. Cardiovasc Res. 1995;29:813-819.
39. Ungureanu-Longrois D, Balligard J-L, Simmons WW, Okada I, Kobzik L, Lowenstein CJ, Kunkel SL, Michel T, Kelly RA, Smith TW. Induction of nitric oxide synthase activity by cytokines in ventricular myocytes is necessary but not sufficient to decrease contractile responsiveness to β-adrenergic agonists. Circ Res. 1995;77:494-502.
40. Rozanski G, Witt RC. IL-1 inhibits beta-adrenergic control of cardiac calcium current: role of L-arginine/nitric oxide pathway. Am J Physiol. 1994;267:H1752-H1758.
41. 2+ transients. FEBS Lett. 1995;376:24-30.
42. Toraason M, Luken ME, Breitenstein M, Krueger JA, Biagini RE. Comparative toxicity of allylamine and acrolein in cultured myocytes and fibroblasts from neonatal rat hearts. Toxicology. 1989;56:107-117.
43. Samuels HH, Stanley F, Casanova J. Depletion of L-3,5,3′-triiodothyroninc and L-thyroxine in euthyroid calf serum for use in cell culture studies of the action of thyroid hormone. Endocrinology. 1979;105:80-85.
44. Bader D, Masaki T, Fischman DA. Immunochemical analysis of myosin heavy chain during avian myogenesis in vivo and in vitro. J Cell Biol. 1982;95:763-770.
45. Chomczynski P, Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem. 1987;162:156-159.
46. Johns D, Feldman A. Identification of a highly conserved region at the 5′ flank of the phospholamban gene. Biochem Biophys Res Commun. 1992;188:927-933.
47. 2+-dependent ATPase from rabbit muscle sarcoplasmic reticulum, deduced from its complementary DNA sequence. Nature. 1985;316:696-700.
48. Fort P, Marry L., Piechaczyk M, Sabrouty S, Dani C, Jeanteur P, Blanchard JM. Various rat adult tissues express only one major inRNA species from the glyceraldehyde-3-phosphate-deliydrogcnase multigenic family. Nucleic Acids Res. 1985;13:1431-1442.
49. Mendez RE, Pfeffer JM, Ortola FV, Bloch KD, Anderson S, Seidman JG, Brenner BM. Atrial natriuretic peptide transcription, storage, and release in rats with myocardial infarction. Am J Physiol. 1987;253:H1449-H1455.
50. Nunokawa Y, Ishida N, Tanaka S. Cloning of inducible nitric oxide synthase in rat vascular smooth muscle cells. Biochem Biophys Res Commun. 1993;191:89-94.
51. Simpson P, McGrath A, Savion S. Myocyte hypertrophy in neonatal rat heart cultures and its regulation by serum and by catecholamines. Circ Res. 1982;51:787-801.
52. Bishopric N, Kedes L. Adrenergic regulation of the skeletal α-actin gene promoter during myocardial cell hypertrophy. Proc Natl Acad Sci USA. 1991;8:2132-2136.
53. Harding P, Carretero O, LaPointe M. Effects of interleukin-1β and nitric oxide on cardiac myocytes. Hypertension, 1995;25:421-430.
54. 2+-independent nitric oxide synthase in the myocardium. Eur J Pharmacol. 1992;105:575-580.
55. Balligand J, Ungureanu-Longrois D, Simmons W, Pimental D, Malinski T, Kapturczak M, Taha Z, Lowenstein C, Davidoff A, Kelly R, Smith T, Michel T. Cytokine-inducible nitric oxide synthase (iNOS) expression in cardiac myocytes. J Biol Chem. 1944;269:27580-27588.
56. Libby P, Warner SJ, Frieman G. Interleukin 1: a mitogen for human vascular smooth muscle cells that induces the release of growth-inhibitory prostanoids. J Clin Invest. 1988;81:487-498.
57. Kracht M, Heiner A, Resch K, Szamel M. Interleukin-1-induced signalling in T-cells. J Biol Chem. 1993;268:21066-21072.
58. Shirakawa F, Mizel SB. In vitro activation and nuclear translocation of NF-kappa B catalyzed by cyclic AMP-derived protein kinase and protein kinase C. Mol Cell Biol. 1989;9:2424-2430.
59. Allo S, Carl L, Morgan H. Acceleration of growth of cultured cardiomyocytes and translocation of protein kinase C. Am J Physiol. 1992;263:C319-C325.
60. Cannon JG, Tomkins RG, Gelfand JA, Michie HR, Stanford GG, van der Meer JWM, Endres S, Lonnemann G, Corsetti J, Chernow B, Wilmore DW, Wolff SM, Dinarello CA. Circulating interleukin-1 and tumor necrosis factor in septic shock and experimental endotoxin fever. J Infect Dis. 1990;161:79-84.
61. Shioi T, Matsumori A, Sasayama S. Persistent expression of cytokine in the chronic since of viral myocarditis in mice. Circulation. 1996;94:2930-2937.
62. Sabine B, Willenbrock R, Haase H, Karczewski P, Wallukat G, Dietz R, Krause E. Cyclic GMP-mediated phospholamban phosphorylation in intact cardiomyocytes. Biochem Biophys Res Commun. 1995;214:75-80.
63. Szymanska G, Grupp I, Slack J, Harrer J, Kranias E. Alterations in sarcoplasmic reticulum calcium uptake, relaxation parameters and their responses to β-adrenergie agonists in the developing rabbit heart. J Mol Cell Cardiol. 1995;27:1819-1825.
64. 2+ in intact cardiac myocytes. Circ Res. 1994;74:970-978.
65. LaPointe M, Sitkins J. Mechanisms of interleukin-1β regulation of nitric oxide synthase in cardiac myocytes. Hypertension. 1996;27:709-714.
66. Ruegg U, Burgess G, Staurosporine, K-252, and UCN-01: potent but non-specific inhibitors of protein kinases. Trends Pharmacol Sci. 1989;10:218-220.
67. Croston G, Cao Z, Goeddel D. NF-κB activation by interleukin-1 (IL-1) requires an IL-1 receptor-associated protein kinase activity. J Biol Chem. 1995;270:16514-16517.
68. Martin M, Bol G, Eriksson A, Resch K, Brigelius-Flohe R. Interleukin-1-induced activation of a protein kinase co-precipitating with the type I interleukin-1 receptor in T cells. Eur J Immunol. 1994;24:1566-1571.
69. Shirakawa F, Chedid M, Suttles J, Pollok BA, Mizel S. Interleukin 1 and cyclic AMP induce kappa immunoglobulin light-chain expression via activation of an NF-kappa B-likc DNA-binding protein. Mol Cell Biol. 1989;9:959-964.
70. Fujii J, Zarain-Herzberg A, Willard H, Tada M, MacLennan D. Structure of the rabbit phospholamban gene, cloning of the human cDNA, and assignment of the gene to human chromosome 6. J Biol Chem. 1991;266:11669-11675.